VERU INC. Accounts Receivable, Allowance for Credit Loss, Current
VERU INC. (VERU) had Accounts Receivable, Allowance for Credit Loss, Current of $3.92 million as of 2024-09-30, per its 10-K filed 2024-12-16.
Financial Statements › Balance Sheet › Assets › Assets, Current › Accounts Receivable, after Allowance for Credit Loss, Current
us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent · last filed 2024-12-16
- 2024-09-30: Accounts Receivable, Allowance for Credit Loss, Current $3.92M.
- 2024-06-30: Accounts Receivable, Allowance for Credit Loss, Current $3.92M.
- 2023-09-30: Accounts Receivable, Allowance for Credit Loss, Current $3.92M.
- 2023-06-30: Accounts Receivable, Allowance for Credit Loss, Current $3.92M.
| Period end | Accounts Receivable, Allowance for Credit Loss, Current | Accounts Receivable, Allowance for Credit Loss, Current as first filed |
|---|---|---|
| 2024-09-30 | $3.92M 10-K · filed 2024-12-16 | |
| 2024-06-30 | $3.92M 10-Q · filed 2024-08-08 | |
| 2023-09-30 | $3.92M 10-K · filed 2024-12-16 | |
| 2023-06-30 | $3.92M 10-Q · filed 2024-08-08 | |
| 2022-09-30 | $12.14K 10-K · filed 2024-12-16 | |
| 2019-12-31 | $33.14K 10-Q · filed 2020-02-12 | |
| 2019-09-30 | $33.14K 10-Q · filed 2020-02-12 | |
| 2019-06-30 | $33.14K 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $36.20K 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $36.20K 10-Q · filed 2019-02-13 | |
| 2018-09-30 | $36.20K 10-K · filed 2019-12-12 | |
| 2018-06-30 | $36.16K 10-Q · filed 2019-08-08 | |
| 2018-03-31 | $36.16K 10-Q · filed 2019-05-15 | |
| 2017-12-31 | $33.10K 10-Q · filed 2019-02-13 | |
| 2017-09-30 | $38.10K 10-K · filed 2019-12-12 | |
| 2017-06-30 | $38.10K 10-Q · filed 2018-08-14 | $38.00K 10-Q · filed 2017-08-09 |
| 2017-03-31 | $38.10K 10-Q · filed 2018-05-11 | $38.00K 10-Q · filed 2017-05-10 |
| 2016-12-31 | $38.10K 10-Q · filed 2018-02-14 | $38.00K 10-Q · filed 2017-02-09 |
| 2016-09-30 | $38.10K 10-K · filed 2018-12-13 | |
| 2016-06-30 | $38.10K 10-Q · filed 2016-07-28 | |
| 2016-03-31 | $38.10K 10-Q · filed 2016-04-28 | |
| 2015-09-30 | $48.07K 10-K · filed 2018-01-02 | |
| 2014-09-30 | $48.07K 10-K · filed 2018-01-02 | |
| 2013-09-30 | $13.18K 10-K · filed 2016-12-12 | |
| 2012-09-30 | $41.63K 10-K · filed 2013-12-03 | |
| 2011-09-30 | $10.00K 10-K · filed 2012-12-04 | |
| 2010-09-30 | $39.80K 10-K · filed 2011-12-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |